Boehringer Ingelheim seeks to help people by researching diseases and developing new medicines and therapies. Our vision "Value through Innovation" is the driver of drug discovery in our worldwide research & development sites. In addition to the development of prominent substances from own research into the treatment of cardiovascular, central nervous system, respiratory, urological and virological disorders, we have successfully advanced our research in oncological, metabolic and thromboembolic diseases.
Discover the story of a drug's development cycle from the first project outline through to market authorisation -the journey of a medicine, from the initial idea to the finished product in a logical, clear and understandable manner.